Skip to main content
Erschienen in: International Urology and Nephrology 4/2013

01.08.2013 | Urology - Original Paper

Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system

verfasst von: Cosimo De Nunzio, Riccardo Lombardo, Riccardo Autorino, Antonio Cicione, Luca Cindolo, Rocco Damiano, Marco De Sio, Mario Falsaperla, Giorgio Franco, Mauro Gacci, Costantino Leonardo, Fabrizio Presicce, Andrea Tubaro

Erschienen in: International Urology and Nephrology | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A modified version of the Clavien system has been recently suggested to allow a standardized assessment of complications associated with transurethral resection of the prostate (TURP). Aim of this multicentre study was to validate the use of this assessment tool in a contemporary cohort of patients undergoing monopolar or bipolar TURP.

Methods

Consecutive patients undergoing TURP in five Italian institutions from April 2011 to March 2012 were prospectively included in this study. Complications occurring within first postoperative month were recorded and graded according to the modified Clavien system. Univariate and binary logistic regression analysis were used for statistical analysis.

Results

Two hundred and ninety-five patients were included in the study. Overall, 47 complications were recorded in 44 patients. There was no difference in terms of postoperative complications between those who underwent monopolar TURP (27 pts; 9.2 %) versus those who underwent bipolar TURP (17 pts; 5.2 %, p = 0.142). Overall perioperative morbidity rate was 15.5 %. Most of the complications were Clavien type I (37 cases; 78 %) and II (6 cases; 12 %). High-grade complications were few as follows: Clavien type IIIb in two cases (4 %) and IV in two cases (4 %). No TURP-related deaths were reported. In the monopolar TURP group, a longer-operative time (OR 1.024; 95 % CI 1.007–1.040, p = 0.004) is an independent predictors of postoperative complications.

Conclusions

A modified Clavien system can be considered a practical and easily applicable tool in grading postoperative complications in patients undergoing TURP. Our findings confirm that TURP is a safe procedure associated with minimal perioperative morbidity.
Literatur
1.
Zurück zum Zitat Rassweiller JSM, Schulze M, Stock C, Teber B, De La Rosette J (2007) Bipolar transurethral resection of the prostate—technical modifications and early clinical experience. Minim Invasive Ther Allied Technol 16:11–21CrossRef Rassweiller JSM, Schulze M, Stock C, Teber B, De La Rosette J (2007) Bipolar transurethral resection of the prostate—technical modifications and early clinical experience. Minim Invasive Ther Allied Technol 16:11–21CrossRef
2.
Zurück zum Zitat Iori F, Franco G, Leonardo C et al (2008) Bipolar transurethral resection of prostate: clinical and urodynamic evaluation. Urology 71:252–255PubMedCrossRef Iori F, Franco G, Leonardo C et al (2008) Bipolar transurethral resection of prostate: clinical and urodynamic evaluation. Urology 71:252–255PubMedCrossRef
3.
Zurück zum Zitat AUA guideline on management of benign prostatic hyperplasia (2003) Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530–547 AUA guideline on management of benign prostatic hyperplasia (2003) Chapter 1: Diagnosis and treatment recommendations. J Urol 170:530–547
4.
Zurück zum Zitat Reich O, Gratzke C, Stief CJ (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970–978PubMedCrossRef Reich O, Gratzke C, Stief CJ (2006) Techniques and long-term results of surgical procedures for BPH. Eur Urol 49:970–978PubMedCrossRef
5.
Zurück zum Zitat Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50:969–979PubMedCrossRef Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 50:969–979PubMedCrossRef
6.
Zurück zum Zitat De Nunzio C, Cindolo L, Leonardo C et al (2013) Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. Eur J Surg Oncol. doi:10.1016/j.ejso.2013.03.008. pii:S0748-7983(13)00318-1 De Nunzio C, Cindolo L, Leonardo C et al (2013) Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. Eur J Surg Oncol. doi:10.​1016/​j.​ejso.​2013.​03.​008. pii:S0748-7983(13)00318-1
7.
Zurück zum Zitat Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M (2013) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Actas Urol Esp 37:1–11PubMedCrossRef Mitropoulos D, Artibani W, Graefen M, Remzi M, Rouprêt M, Truss M (2013) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Actas Urol Esp 37:1–11PubMedCrossRef
8.
9.
10.
Zurück zum Zitat Bruce J, Russell EM, Mollison J, KruKowski ZH (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5:1–194PubMed Bruce J, Russell EM, Mollison J, KruKowski ZH (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5:1–194PubMed
11.
Zurück zum Zitat Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526PubMed Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526PubMed
12.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196PubMedCrossRef
13.
Zurück zum Zitat Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184–190PubMedCrossRef Tefekli A, Ali Karadag M, Tepeler K et al (2008) Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 53:184–190PubMedCrossRef
14.
Zurück zum Zitat Mandal S, Sankhwar SN, Kathpalia R et al (2013) Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol 45:347–354PubMedCrossRef Mandal S, Sankhwar SN, Kathpalia R et al (2013) Grading complications after transurethral resection of prostate using modified Clavien classification system and predicting complications using the Charlson comorbidity index. Int Urol Nephrol 45:347–354PubMedCrossRef
15.
Zurück zum Zitat Mamoulakis C, Skolarikos A, Schulze M (2012) Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int 109:240–248PubMedCrossRef Mamoulakis C, Skolarikos A, Schulze M (2012) Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int 109:240–248PubMedCrossRef
16.
Zurück zum Zitat Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205–210PubMedCrossRef Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29:205–210PubMedCrossRef
17.
Zurück zum Zitat Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87:450–459PubMed Holtgrewe HL, Valk WL (1962) Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. J Urol 87:450–459PubMed
18.
Zurück zum Zitat Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M (2005) Prostate study group of the Austrian society of urology. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504PubMedCrossRef Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M (2005) Prostate study group of the Austrian society of urology. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504PubMedCrossRef
19.
Zurück zum Zitat Mamoulakis C, Schulze M, Skolarikos A et al (2013) Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol 63:667–676PubMedCrossRef Mamoulakis C, Schulze M, Skolarikos A et al (2013) Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol 63:667–676PubMedCrossRef
20.
Zurück zum Zitat Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83:227–237PubMedCrossRef Madersbacher S, Marberger M (1999) Is transurethral resection of the prostate still justified? BJU Int 83:227–237PubMedCrossRef
21.
Zurück zum Zitat Issa MM (2008) Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol 22:1587–1595PubMedCrossRef Issa MM (2008) Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. J Endourol 22:1587–1595PubMedCrossRef
22.
Zurück zum Zitat Mamoulakis C, Ubbink DT, de la Rosette JJ (2009) Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol 56:798–809PubMedCrossRef Mamoulakis C, Ubbink DT, de la Rosette JJ (2009) Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol 56:798–809PubMedCrossRef
23.
Zurück zum Zitat Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52:517–522PubMedCrossRef Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52:517–522PubMedCrossRef
24.
Zurück zum Zitat Autorino R, Damiano R, Di Lorenzo G et al (2009) Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol 55:922–929PubMedCrossRef Autorino R, Damiano R, Di Lorenzo G et al (2009) Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol 55:922–929PubMedCrossRef
25.
Zurück zum Zitat Lourenco T, Armstrong N, N’Dow J et al (2008) Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 12:1–146 Lourenco T, Armstrong N, N’Dow J et al (2008) Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 12:1–146
26.
Zurück zum Zitat De Nunzio C, Ahayai S, Autorino R et al (2011) Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. Eur Urol 60(6):1205–1206PubMedCrossRef De Nunzio C, Ahayai S, Autorino R et al (2011) Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. Eur Urol 60(6):1205–1206PubMedCrossRef
Metadaten
Titel
Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system
verfasst von
Cosimo De Nunzio
Riccardo Lombardo
Riccardo Autorino
Antonio Cicione
Luca Cindolo
Rocco Damiano
Marco De Sio
Mario Falsaperla
Giorgio Franco
Mauro Gacci
Costantino Leonardo
Fabrizio Presicce
Andrea Tubaro
Publikationsdatum
01.08.2013
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2013
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0476-1

Weitere Artikel der Ausgabe 4/2013

International Urology and Nephrology 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.